High-Intensity Interval Training for Walking and Function Across Different Multiple Sclerosis Disability Levels

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorHacettepe University

About this trial

Multiple Sclerosis (MS) is a chronic neurological disease that can affect daily functioning, mobility, and overall quality of life. High-Intensity Interval Training (HIIT) is known to be a time-efficient exercise approach that improves exercise capacity and reduces fatigue in MS. However, current research lacks sufficient data on how HIIT affects individuals with different levels of disability.

The main purpose of this study is to evaluate the effects of a stationary bicycle-based HIIT protocol on maximum walking distance, fatigue, balance, muscle strength, endurance, gait speed, and quality of life in MS patients across three different disability levels: mild, moderate, and severe (classified according to Expanded Disability Status Scale - EDSS scores).

Participants will complete a cycle ergometer-based HIIT program. Assessments will be conducted at three time points:

Before starting the exercise program (baseline)

Immediately after completing the program (post-treatment)

4 weeks after the completion of the program (follow-up)

To ensure unbiased results, a triple-blind design will be used, meaning the outcome assessor, the treating physiotherapist, and the data analyst will be blinded to group assignments. The findings aim to help clinicians tailor personalized, effective HIIT protocols based on a patient's specific disability level rather than using a standardized, one-size-fits-all approach in MS rehabilitation.

Eligibility criteria

Qualifiers

Be between the ages of 18 and 65,

Have been diagnosed with MS by a treating physician,

Have an EDSS score between 0 and 6.5,

Not having experienced a relapse within the last 3 months,

Disqualifiers

Having a severe cardiovascular, orthopedic, respiratory, or metabolic disease,

Having an additional neurological condition,

Being pregnant or suspecting pregnancy,

Having received a botulinum toxin injection within the last 3 months,

Trial design

Treatments tested in this trial

  • High-Intensity Interval Training

Treatment groups

30 Participants
are divided into 3 treatment groups

Sponsors and collaborators